Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Sonnet BioTherapeutics Holdings, Inc. from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q2 2019 to Q3 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2024 was $12.8K, a 61.6% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12.8K -$20.6K -61.6% 30 Sep 2024 10-K 17 Dec 2024
Q3 2023 $33.4K -$27.9K -45.5% 30 Sep 2023 10-K 14 Dec 2023
Q3 2022 $61.3K +$48.3K +372% 30 Sep 2022 10-K 15 Dec 2022
Q2 2022 $69.3K +$52.4K +309% 30 Jun 2022 10-Q 15 Aug 2022
Q3 2021 $13K -$19.5K -59.9% 30 Sep 2021 10-K 17 Dec 2021
Q2 2021 $17K -$21.9K -56.3% 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 $21.5K 31 Mar 2021 10-Q 17 May 2021
Q4 2020 $26.6K -$9.95M -99.7% 31 Dec 2020 10-Q 16 Feb 2021
Q3 2020 $32.5K -$10M -99.7% 30 Sep 2020 10-K 17 Dec 2020
Q2 2020 $38.9K -$11.2M -99.7% 30 Jun 2020 10-Q 14 Aug 2020
Q4 2019 $9.98M 31 Dec 2019 10-K 19 Mar 2020
Q3 2019 $10.1M 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $11.3M 30 Jun 2019 10-Q 14 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.